Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 4, 2025 • 1:30 AM ET

Date/Time Source News Release
02/27/2025 08:00 AM EST GlobeNewswire Fusion Fuel Appoints Luisa Ingargiola to Board of Directors
08/15/2024 08:30 AM EDT GlobeNewswire BioCorRx Reports Business Update for the Second Quarter of 2024
04/03/2024 08:30 AM EDT GlobeNewswire BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
04/02/2024 08:30 AM EDT GlobeNewswire BioCorRx Reports Business Update for 2023
02/28/2024 10:49 AM EST GlobeNewswire BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
02/08/2024 09:52 AM EST GlobeNewswire BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
01/09/2024 08:30 AM EST GlobeNewswire BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
08/15/2023 09:00 AM EDT GlobeNewswire BioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder
08/14/2023 04:34 PM EDT GlobeNewswire BioCorRx Reports Business Update for the Second Quarter of 2023
07/18/2023 08:30 AM EDT GlobeNewswire BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
Page

Additional News

As of April 4, 2025 • 1:30 AM ET

Date/Time Source News Release
03/10/2025 08:37 AM EDT NewMediaWire BioCorRx Pharmaceuticals Inc. Announces That it has Acquired LUCEMYRA(R) (lofexidine), an FDA-Approved Opioid Withdrawal Medication, From USWM, LLC
11/13/2024 04:44 AM EST US Earnings Reports Expected earnings - BioCorRx Inc
08/12/2024 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, August 12th, 2024
08/12/2024 05:45 AM EDT US Earnings Reports Expected earnings - BioCorRx Inc
05/16/2024 08:36 AM EDT NewMediaWire BioCorRx Reports Business Update for the First Quarter of 2024
04/03/2024 08:49 AM EDT SeekingAlpha BioCorRx receives new patent for novel compound to treat pain, depression, and schizophrenia
03/26/2024 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 26th, 2024
03/26/2024 05:31 AM EDT US Earnings Reports Expected earnings - BioCorRx Inc
03/19/2024 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 19th, 2024
03/19/2024 05:32 AM EDT US Earnings Reports Expected earnings - BioCorRx Inc
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.